Safe, Effective, and Inexpensive Clearance of Mycoplasma Contamination from Cultures of Apicomplexan Parasites with Sparfloxacin
Open accessPublished version of a preprint
The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
These findings will be useful to laboratories maintaining apicomplexan parasites in vitro , especially in low-resource environments, where the high cost of commercial products creates an economic barrier for detecting and eliminating mycoplasma from culture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Modern broad-spectrum antibiotics can effectively combat various types of mycoplasmas while preserving valuable cell lines from destruction [75].”
From Mycoplasma Contamination of Primary Cell Cultures (2026) · cites this paper as [75]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening
Smilkstein, M., Sriwilaijaroen, N., Kelly, J. X., Wilairat, P., & Riscoe, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1803-1806.2004 · Cited by 1,210
Interaction of Mycoplasmas With Host Cells
Rottem, S. (2003) · Physiological Reviews · doi:10.1152/physrev.00030.2002 · Cited by 432
Drexler, H. G., & Uphoff, C. C. (2002) · Cytotechnology · doi:10.1023/a:1022913015916 · Cited by 340
Antimicrobial Resistance in Mycoplasma spp
Gautier-Bouchardon, A. V. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0030-2018 · Cited by 207 · cited 1×
“tetracyclines, macrolides, and quinolones (5).”
Kirkman, L. A., Zhan, W., Visone, J. E., Dziedziech, A., Singh, P. K., Fan, H., Tong, X., Bruzual, I., Hara, R., Kawasaki, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806109115 · Cited by 107
Self-citationCytological and immunological responses toBabesia divergens in different hosts: Ox, gerbil, man
Gorenflot, A. F., Brasseur, P., Précigout, É., L’Hostis, M., Marchand, A., & Schrével, J. (1991) · Parasitology Research · doi:10.1007/bf00934377 · Cited by 106
In Vitro Activities of Antibiotics against Plasmodium falciparum Are Inhibited by Iron
Pradines, B., Rogier, C., Fusaı̈, T., Mosnier, J., Daries, W., Barret, E., & Parzy, D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1746-1750.2001 · Cited by 103
Boyce, S. T., Warden, G. D., & Holder, I. A. (1995) · Journal of Burn Care & Rehabilitation · doi:10.1097/00004630-199503000-00002 · Cited by 91 · cited 1×
“was found to reduce the viability and growth of cell lines that expressed high levels of HERG (18), but sparfloxacin had no significant effect on growth of fibroblast cultures below 100mg/ml (19).”
BackgroundMahmoudi, N., Cicéron, L., Franetich, J., Farhati, K., Silvie, O., Eling, W. M. C., Sauerwein, R. W., Danis, M., Mazier, D., & Derouin, F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2636-2639.2003 · Cited by 88
In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas
Bebear, C. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.5.711 · Cited by 84
Research works printed but not linked: 2
- McGarrity GJ, Barile MF. 1983. Methods in mycoplasmology: diagnostic mycoplasmology, vol 2. Academic Press, New York, NY.
- Schlichtherle M, Wahlgren M, Perlmann H, Scherf A (ed). 2000. Methods in malaria research, 3rd ed. MR4/American Type Culture Collection, Manassas, VA.
Cited by
CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification
Quansah, E., Chen, Y., Yang, S., Wang, J., Sun, D., Zhao, Y., Chen, M., Li, Y., & Zhang, C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1076947 · Cited by 18
Леонович, О. А. (2024) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683824604943 · Cited by 8
Bower-Lepts, C., Jangra, A., Kanatani, S., Tripathi, A., Mlambo, G., McCotter-Gonzalez, A., Romano, L., Orena, S., Okitwi, M., Niaré, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.05.722990 · Cited by 7
Song, S., Li, F., Zhao, B., Xu, Y., Liu, Z., Liu, J., Hou, Q., Chen, J., Chen, M., Liu, Z., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117167 · Cited by 2
Mycoplasma Contamination of Primary Cell Cultures
A. Leonovich, O. (2026) · Biochemistry · doi:10.5772/intechopen.1013412 · Cited by 1
Metadata
- Authors
- Malave-Ramos, D. R., Kennedy, K., Key, M. N., Dou, Z., & Kafsack, B. F. C.
- Affiliations
- Cornell University (US)
- Weill Cornell Medicine (US)
- Clemson University (US)
- Corresponding author
- Kennedy, Kit
- Kafsack, Björn F. C.
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2022-10-26
- Volume
- 10
- Issue
- 5
- Pages
- e0349722-e0349722
- ISSN
- 2165-0497 (ISSN-L)
- PMC
- PMC9603166
- OpenAlex
- W4300690496
- Cited by
- 4
- References
- 23
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1
- FWCI
- 0.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology Spectrum (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HHS | NIH | National Institute of Allergy and Infectious Diseases (1R01 AI141965, 1R01 AI138499, 1R21 AI166436, 1R01 AI143707)
- Frueauff Family Foundation
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Life Sciences › Immunology and Microbiology › Parasitology › Toxoplasma gondii Research Studies
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Keywords
- mycoplasma contamination, Apicomplexa, sparfloxacin, low-resource laboratories
- MeSH terms
- Animals, Anti-Bacterial Agents, Mycoplasma, Parasites, Fluoroquinolones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.